{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T18:22:20Z","timestamp":1701454940071},"reference-count":129,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1159\/000055822","type":"journal-article","created":{"date-parts":[[2003,4,15]],"date-time":"2003-04-15T19:06:20Z","timestamp":1050433580000},"page":"267-274","source":"Crossref","is-referenced-by-count":3,"title":["On the Role of Islet Amyloid Polypeptide in Glucose Intolerance and Anorexia of Pancreatic Cancer"],"prefix":"10.1016","volume":"1","author":[{"given":"Margery K.","family":"Herrington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urban","family":"Arnelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Permert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1159\/000055822_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/pgmj.75.887.521","article-title":"Pancreatic cancer: Any prospects for prevention?","volume":"75","author":"Hart","year":"1999","journal-title":"Postgrad Med J"},{"key":"10.1159\/000055822_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(96)05523-7","article-title":"Pancreatic carcinoma","volume":"349","author":"Rosewicz","year":"1997","journal-title":"Lancet"},{"key":"10.1159\/000055822_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.2910540413","article-title":"Estimates of the worldwide incidence of eighteen major cancers in 1985","volume":"54","author":"Parkin","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1159\/000055822_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0305-7372(98)90079-2","article-title":"Chemotherapy in advanced pancreatic adenocarcinoma","volume":"24","author":"Kollmannsberger","year":"1998","journal-title":"Cancer Treat Rev"},{"key":"10.1159\/000055822_bib5","first-page":"483","article-title":"Carcinoma of the pancreas: Critical analysis of costs, results of resections, and the need for standardized reporting","volume":"181","author":"Gudjonsson","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1159\/000055822_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1200\/JCO.1999.17.2.585","article-title":"Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer","volume":"17","author":"Hidalgo","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1159\/000055822_bib7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2165\/00003495-200059050-00004","article-title":"Pancreatic cancer: A review of emerging therapies","volume":"59","author":"Rosenberg","year":"2000","journal-title":"Drugs"},{"key":"10.1159\/000055822_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00001574-199110000-00009","article-title":"Cancer of the pancreas","volume":"7","author":"Livingston","year":"1991","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1159\/000055822_bib9","first-page":"397","article-title":"Pancreatic cancer","volume":"56","author":"Kalser","year":"1985","journal-title":"Assessment of prognosis by clinical presentation. Cancer"},{"key":"10.1159\/000055822_bib10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0300-5089(21)00766-5","article-title":"Pancreatic carcinoma: Diagnosis and treatment","volume":"13","author":"Ihse","year":"1984","journal-title":"Clin Gastroenterol"},{"key":"10.1159\/000055822_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02924237","article-title":"Effectiveness of multimodality treatment for resectable pancreatic cancer","volume":"7","author":"Ozaki","year":"1990","journal-title":"Int J Pancreatol"},{"key":"10.1159\/000055822_bib12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2","article-title":"Causes of death in cancer patients","volume":"33","author":"Inagami","year":"1974","journal-title":"Cancer"},{"key":"10.1159\/000055822_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM194610312351805","article-title":"The diagnosis of cancer of the pancreas","volume":"235","author":"Ingelfinger","year":"1946","journal-title":"N Engl J Med"},{"key":"10.1159\/000055822_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF02927065","article-title":"Improvement of pancreatic cancer treatment from the Japanese experience in the 1980s","volume":"12","author":"Ozaki","year":"1992","journal-title":"Int J Pancreatol"},{"key":"10.1159\/000055822_bib15","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/jnci\/91.18.1532","article-title":"Pancreatic cancer research: Putting all their ducts in a row","volume":"91","author":"Kuska","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1159\/000055822_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJM199402033300503","article-title":"Islet amyloid polypeptide in patients with pancreatic cancer patients and diabetes","volume":"330","author":"Permert","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1159\/000055822_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00500385","article-title":"Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients","volume":"34","author":"Sanke","year":"1991","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/00365529609031632","article-title":"Effects of acute and chronic infusion of islet amyloid polypeptide on food intake in rats","volume":"31","author":"Arnelo","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1159\/000055822_bib19","first-page":"R1654","article-title":"Chronic infusion of islet amyloid polypeptide causes anorexia in rats","volume":"271","author":"Arnelo","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1159\/000055822_bib20","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/en.138.10.4081","article-title":"Chronic low dose islet amyloid polypeptide infusion reduces food intake but does not influence glucose metabolism in unrestrained conscious rats: Studies using a novel aortic catheterization technique","volume":"138","author":"Arnelo","year":"1997","journal-title":"Endocrinology"},{"key":"10.1159\/000055822_bib21","first-page":"R1537","article-title":"Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats","volume":"275","author":"Arnelo","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1159\/000055822_bib22","first-page":"577","article-title":"IAPP as a regulator of glucose homeostasis and pancreatic hormone secretion","volume":"3","author":"Karlsson","year":"1999","journal-title":"Int J Mol Med"},{"key":"10.1159\/000055822_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1159\/000055822_bib24","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma islets of Langerhans of the diabetic cat are derived from the neuropeptide like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1159\/000055822_bib25","first-page":"414","article-title":"Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone","volume":"127","author":"Westermark","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1159\/000055822_bib26","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1159\/000055822_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0014-5793(90)80314-9","article-title":"The human islet amyloid polypeptide gene. Organization, chromosomal localization and identification of a promoter region","volume":"267","author":"Christmanson","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1159\/000055822_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00401195","article-title":"Islet amyloid polypeptide \u2014 A novel controversy in diabetic research","volume":"35","author":"Westermark","year":"1992","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF00400929","article-title":"Islet amyloid polypeptide immunoreactivity in the human fetal pancreas","volume":"35","author":"In't Veld","year":"1992","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1055\/s-2007-978777","article-title":"The effect of pramlintide (amylin analogue) treatment on bone metabolism and bone density in patients with type 1 diabetes mellitus","volume":"31","author":"Borm","year":"1999","journal-title":"Horm Metab Res"},{"key":"10.1159\/000055822_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00285291","article-title":"Co-localization of islet amyloid polypeptide and insulin and the B cell secretory granules of the human pancreatic islets","volume":"32","author":"Lukinius","year":"1989","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2337\/diabetes.39.6.752","article-title":"Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans","volume":"39","author":"Butler","year":"1990","journal-title":"Diabetes"},{"key":"10.1159\/000055822_bib33","first-page":"E156","article-title":"Direct plasma radioimmunoassay for rat amylin-(1\u201337): Concentrations with acquired and genetic obesity","volume":"267","author":"Pieber","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1159\/000055822_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-5793(95)01460-8","article-title":"Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2","volume":"378","author":"Badman","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1159\/000055822_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00401050","article-title":"Lack of effect of amylin amide on carbohydrate metabolism in man","volume":"33","author":"Bretherton-Watt","year":"1990","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/bbrc.1999.1943","article-title":"Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product","volume":"267","author":"Zumpe","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1159\/000055822_bib37","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1210\/en.140.6.2924","article-title":"An amylin receptor is revealed following co-trans-fection of a clacitonin receptor with receptor activity modifying proteins-1 or -3","volume":"140","author":"Muff","year":"1999","journal-title":"Endocrinology"},{"key":"10.1159\/000055822_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin gene-related peptide: Structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr Rev"},{"key":"10.1159\/000055822_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.48.2.241","article-title":"Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes","volume":"48","author":"Kahn","year":"1999","journal-title":"Diabetes"},{"key":"10.1159\/000055822_bib40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1006\/jmbi.1999.3422","article-title":"Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties","volume":"295","author":"Tenidis","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1159\/000055822_bib41","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1159\/000055822_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2007-979042","article-title":"Transgenic overproduction of islet amyloid polypeptide (amylin) is not sufficient for islet amyloid formation","volume":"29","author":"Verchere","year":"1997","journal-title":"Horm Metab Res"},{"key":"10.1159\/000055822_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.5.5.527","article-title":"The relation of diabetes mellitus to lesions of the pancreas: Hyaline degeneration of the islets of Langerhans","volume":"5","author":"Opie","year":"1901","journal-title":"J Exp Med"},{"key":"10.1159\/000055822_bib44","first-page":"968","article-title":"Zur Kenntniss der feineren Veranderungen des Pankreas bei Diabetes mellitus","volume":"41","author":"Weichselbaum","year":"1901","journal-title":"Wien Klin Wochenschr"},{"key":"10.1159\/000055822_bib45","first-page":"47","article-title":"Amyloid and polypeptide hormones: What is their relationship?","volume":"1","author":"Westermark","year":"1994","journal-title":"Amyloid Int J Exp Clin Invest"},{"key":"10.1159\/000055822_bib46","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0046-8177(81)80197-9","article-title":"The relation of islet amyloid to the clinical type of diabetes","volume":"12","author":"Maloy","year":"1981","journal-title":"Hum Pathol"},{"key":"10.1159\/000055822_bib47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1159\/000055822_bib48","first-page":"E684","article-title":"Islet amyloid polypeptide (amylin)-deficient mice develop a more severe form of alloxan-induced diabetes","volume":"278","author":"Mulder","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1159\/000055822_bib49","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","article-title":"Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide","volume":"93","author":"Verchere","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1159\/000055822_bib50","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<637::AID-IJC15>3.0.CO;2-8","article-title":"Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia","volume":"72","author":"Oosterwijk","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1159\/000055822_bib51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0016-5085(98)70641-9","article-title":"Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin","volume":"114","author":"Ding","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1159\/000055822_bib52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00006676-199905000-00012","article-title":"Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells","volume":"18","author":"Wang","year":"1999","journal-title":"Pancreas"},{"key":"10.1159\/000055822_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF02822387","article-title":"Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines","volume":"21","author":"Wang","year":"1997","journal-title":"Int J Pancreatol"},{"key":"10.1159\/000055822_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ajcp\/100.3.223","article-title":"Endocrine aspects of exocrine cancer of the pancreas. Their patterns and suggested biologic significance","volume":"100","author":"Pour","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"10.1159\/000055822_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/1520-6866(2001)21:1<59::AID-TCM6>3.0.CO;2-V","article-title":"Early changes in islet hormone secretion in the hamster pancreatic cancer model","volume":"21","author":"Permert","year":"2001","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1159\/000055822_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/09595287330180P102","article-title":"Cases and observations connected with disease of the pancreas and duodenum","volume":"18","author":"Bright","year":"1833","journal-title":"Med Chir Tr"},{"key":"10.1159\/000055822_bib57","first-page":"499","article-title":"Carcinoma of the pancreas II. The relation of carcinoma of the pancreas to diabetes mellitus","volume":"33","author":"Bell","year":"1957","journal-title":"Am J Pathol"},{"key":"10.1159\/000055822_bib58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/diab.7.4.308","article-title":"Diabetes mellitus in association with primary carcinoma of the pancreas","volume":"7","author":"Green","year":"1958","journal-title":"Diabetes"},{"key":"10.1159\/000055822_bib59","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.2.5262.1259","article-title":"Diabetes and primary cancer of the pancreas","volume":"ii","author":"Clark","year":"1961","journal-title":"Br Med J"},{"key":"10.1159\/000055822_bib60","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.7326\/0003-4819-48-6-1171","article-title":"Carcinoma of the pancreas: A clinical study based on 84 cases","volume":"48","author":"Birnbaum","year":"1958","journal-title":"Ann Intern Med"},{"key":"10.1159\/000055822_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0025-7125(16)33598-2","article-title":"Abnormal carbohydrate metabolism in pancreatic carcinoma","volume":"47","author":"Murphy","year":"1963","journal-title":"Med Clin North Am"},{"key":"10.1159\/000055822_bib62","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/bjs.1800560512","article-title":"The association between carcinoma of the pancreas and diabetes mellitus","volume":"56","author":"Karmody","year":"1969","journal-title":"Br J Surg"},{"key":"10.1159\/000055822_bib63","first-page":"123","article-title":"Diabetes and pancreatic cancer","volume":"52","author":"Sperti","year":"1992","journal-title":"Digestion"},{"key":"10.1159\/000055822_bib64","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/BF01072886","article-title":"A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma","volume":"23","author":"Schwartz","year":"1978","journal-title":"Am J Dig Dis"},{"key":"10.1159\/000055822_bib65","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/1097-0142(19910115)67:2<486::AID-CNCR2820670228>3.0.CO;2-1","article-title":"Insulin secretion and action in patients with pancreatic cancer","volume":"67","author":"Cersosimo","year":"1991","journal-title":"Cancer"},{"key":"10.1159\/000055822_bib66","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000441-196202000-00023","article-title":"The intravenous tolbutamide test as a diagnostic aid in carcinoma of the pancreas","volume":"243","author":"Berkowitz","year":"1963","journal-title":"Am J Med Sci"},{"key":"10.1159\/000055822_bib67","first-page":"77","article-title":"C-peptide pattern in patients with pancreatic cancer","volume":"52","author":"Del Favero","year":"1992","journal-title":"Digestion"},{"key":"10.1159\/000055822_bib68","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/bjs.1800800841","article-title":"Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer","volume":"80","author":"Permert","year":"1993","journal-title":"Br J Surg"},{"key":"10.1159\/000055822_bib69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM199407143310203","article-title":"Diabetes and the risk of pancreatic cancer","volume":"331","author":"Gullo","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1159\/000055822_bib70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02576207","article-title":"Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster","volume":"193","author":"Ahren","year":"1993","journal-title":"Res Exp Med"},{"key":"10.1159\/000055822_bib71","first-page":"145","article-title":"Diabetic mortality in Australia","volume":"7","author":"Lancaster","year":"1958","journal-title":"Aust Ann Med"},{"key":"10.1159\/000055822_bib72","first-page":"673","article-title":"Cancer mortality among diabetics","volume":"44","author":"Kessler","year":"1970","journal-title":"J Natl Cancer Inst"},{"key":"10.1159\/000055822_bib73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0021-9681(82)90025-X","article-title":"Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus","volume":"35","author":"Regazzino","year":"1982","journal-title":"J Chron Dis"},{"key":"10.1159\/000055822_bib74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ijc.2910430312","article-title":"Pancreatic cancer, alcohol, diabetes mellitus and gallbladder disease","volume":"43","author":"Cuzick","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1159\/000055822_bib75","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jama.1995.03520440059037","article-title":"Diabetes mellitus as a risk factor for pancreatic cancer: A meta-analysis","volume":"273","author":"Everhart","year":"1995","journal-title":"JAMA"},{"key":"10.1159\/000055822_bib76","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1464-5491.1984.tb01941.x","article-title":"Pancreatic cancer and diabetes mellitus","volume":"1","author":"Morris","year":"1984","journal-title":"Diabetic Med"},{"key":"10.1159\/000055822_bib77","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.1981.03310270027018","article-title":"A multifactorial model for pancreatic cancer in man: Epidemiologic evidence","volume":"245","author":"Lin","year":"1981","journal-title":"JAMA"},{"key":"10.1159\/000055822_bib78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF00273858","article-title":"Frequency of cancer among insulin-treated diabetic patients in Denmark","volume":"28","author":"Green","year":"1985","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9610(05)80405-2","article-title":"Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?","volume":"165","author":"Permert","year":"1993","journal-title":"Am J Surg"},{"key":"10.1159\/000055822_bib80","first-page":"2827","article-title":"Diabetes mellitus in pancreatic cancer follow-up","volume":"14","author":"Fogar","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1159\/000055822_bib81","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00401051","article-title":"Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs","volume":"33","author":"Sowa","year":"1990","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib82","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/335632a0","article-title":"Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro","volume":"335","author":"Leighton","year":"1988","journal-title":"Nature"},{"key":"10.1159\/000055822_bib83","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2337\/diabetes.39.2.260","article-title":"Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide","volume":"39","author":"Molina","year":"1990","journal-title":"Diabetes"},{"key":"10.1159\/000055822_bib84","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1210\/jc.74.5.1032","article-title":"Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man","volume":"74","author":"Bretherton-Watt","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1159\/000055822_bib85","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1530\/acta.0.1290360","article-title":"Insulin resistance caused by amylin in conscious rats is independent of induced hypocalcemia and fades during long-term exposure","volume":"129","author":"F\u00fcrnsinn","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1159\/000055822_bib86","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2337\/diabetes.40.5.568","article-title":"In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glucogen synthesis in skeletal muscle","volume":"40","author":"Frontoni","year":"1991","journal-title":"Diabetes"},{"key":"10.1159\/000055822_bib87","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-291X(90)92053-3","article-title":"The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in cats","volume":"167","author":"Johnson","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1159\/000055822_bib88","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-8227(92)90142-E","article-title":"Homologous islet amyloid polypeptide: Effects on plasma levels of glucagon, insulin and glucose in the mouse","volume":"18","author":"Panagiotidis","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1159\/000055822_bib89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0168-8227(92)90016-K","article-title":"Effects of aging on plasma islet amyloid polypeptide basal level and response to oral glucose load","volume":"15","author":"Mitsukawa","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1159\/000055822_bib90","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/0006-291X(91)92078-X","article-title":"Amylin is more potent and more effective than glucagon in raising plasma glucose concentration in fasted, anesthetized rats","volume":"181","author":"Wang","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1159\/000055822_bib91","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/07435809209111040","article-title":"Induction of acute hyperglycemia, hyperlactemia and hypocalcemia in fed and fasted BALB\/c mice by intravenous amylin injection","volume":"8","author":"Wang","year":"1992","journal-title":"Endocr Res"},{"key":"10.1159\/000055822_bib92","first-page":"E943","article-title":"Response to intravenous injection of amylin and glucagon in fasted, fed, and hypoglycemic rats","volume":"264","author":"Young","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1159\/000055822_bib93","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/0024-3205(93)90480-Q","article-title":"Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRPa) in the fasted, anesthetized rat","volume":"52","author":"Young","year":"1993","journal-title":"Life Sci"},{"key":"10.1159\/000055822_bib94","first-page":"E457","article-title":"Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro","volume":"259","author":"Young","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1159\/000055822_bib95","first-page":"E531","article-title":"Amylin-mediated inhibition of insulin-stimulated glucose transport in skeletal muscle","volume":"275","author":"Castle","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1159\/000055822_bib96","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF00405079","article-title":"Amylin-induced in vivo insulin resistance in conscious rats: The liver is more sensitive to amylin than peripheral tissues","volume":"34","author":"Koopmans","year":"1991","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s001250050088","article-title":"Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans","volume":"37","author":"Wilding","year":"1994","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib98","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/BF00400360","article-title":"Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule","volume":"36","author":"Stridsberg","year":"1993","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib99","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-4889(92)90260-I","article-title":"Amylin inhibits insulin-stimulated glucose uptake in C2C12 muscle cell line through a cholera-toxin-sensitive mechanism","volume":"1136","author":"Sheriff","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1159\/000055822_bib100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/bbrc.1998.9308","article-title":"Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin)","volume":"250","author":"Gebre-Medhin","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1159\/000055822_bib101","first-page":"E19","article-title":"Islet amyloid polypeptide tonally inhibits \u03b2-, \u03b1-, and \u03b4-cell secretion in isolated rat pancreatic islets","volume":"276","author":"Wang","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1159\/000055822_bib102","first-page":"E300","article-title":"Islet amyloid polypeptide inhibits insulin secretion in conscious rats","volume":"267","author":"Furnsinn","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1159\/000055822_bib103","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0006-291X(90)90524-Q","article-title":"Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas","volume":"170","author":"O'Brien","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1159\/000055822_bib104","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/0006-291X(90)90636-2","article-title":"Islet amyloid polypeptide (IAPP; amylin) influences the endocrine but not the exocrine rat pancreas","volume":"167","author":"Fehmann","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1159\/000055822_bib105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/diabetes.41.8.975","article-title":"In vitro effects of amylin on carbohydrate metabolism in liver cells","volume":"41","author":"Cliaraldi","year":"1992","journal-title":"Diabetes"},{"key":"10.1159\/000055822_bib106","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2337\/diabetes.40.3.395","article-title":"Presence of liver CGRP\/amylin receptors in only nonparenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP\/amylin","volume":"40","author":"Stephens","year":"1991","journal-title":"Diabetes"},{"key":"10.1159\/000055822_bib107","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0026-0495(97)90170-0","article-title":"Dose- response for glucagonostatic effect of amylin in rats","volume":"46","author":"Gedulin","year":"1997","journal-title":"Metabolism"},{"key":"10.1159\/000055822_bib108","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/bjc.1997.17","article-title":"Changes in nutritional status associated with unresectable pancreatic cancer","volume":"75","author":"Wigmore","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1159\/000055822_bib109","doi-asserted-by":"crossref","first-page":"243S","DOI":"10.1093\/jn\/129.1.243S","article-title":"Wasting in cancer","volume":"129","author":"Tisdale","year":"1999","journal-title":"J Nutr"},{"key":"10.1159\/000055822_bib110","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jnci\/89.23.1763","article-title":"Biology of cachexia","volume":"89","author":"Tisdale","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1159\/000055822_bib111","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00000658-199404000-00001","article-title":"Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer","volume":"219","author":"Falconer","year":"1994","journal-title":"Ann Surg"},{"key":"10.1159\/000055822_bib112","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/bjs.1800840214","article-title":"Contribution of anorexia and hyper-metabolism to weight loss in anicteric patients with pancreatic cancer","volume":"84","author":"Wigmore","year":"1997","journal-title":"Br J Surg"},{"key":"10.1159\/000055822_bib113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2168.2000.01317.x","article-title":"Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor","volume":"87","author":"Wigmore","year":"2000","journal-title":"Br J Surg"},{"key":"10.1159\/000055822_bib114","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00075197-199805000-00003","article-title":"New cachexic factors","volume":"1","author":"Tisdale","year":"1998","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1159\/000055822_bib115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0031-9384(94)90076-0","article-title":"Reduction in food intake in rats by intraperitoneal injection of low doses of amylin","volume":"55","author":"Lutz","year":"1994","journal-title":"Physiol Behav"},{"key":"10.1159\/000055822_bib116","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0196-9781(98)00114-4","article-title":"Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats","volume":"19","author":"Lutz","year":"1998","journal-title":"Peptides"},{"key":"10.1159\/000055822_bib117","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0196-9781(91)90038-Q","article-title":"Syntheses, structures and anorectic effects of human and rat amylin","volume":"12","author":"Balasubramaniam","year":"1991","journal-title":"Peptides"},{"key":"10.1159\/000055822_bib118","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0006-8993(91)91644-G","article-title":"Anorexia following the intrahypothalamic administration of amylin","volume":"39","author":"Chance","year":"1991","journal-title":"Brain Res"},{"key":"10.1159\/000055822_bib119","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0196-9781(92)90057-A","article-title":"Test of adipsia and conditioned taste aversion following intrahypothalamic injection of amylin","volume":"13","author":"Chance","year":"1992","journal-title":"Peptides"},{"key":"10.1159\/000055822_bib120","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0196-9781(91)90148-I","article-title":"Amylin decreases food intake in mice","volume":"12","author":"Morley","year":"1991","journal-title":"Peptides"},{"key":"10.1159\/000055822_bib121","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-0115(95)00009-Z","article-title":"In vivo central actions of rat amylin","volume":"56","author":"Bouali","year":"1995","journal-title":"Regul Pept"},{"key":"10.1159\/000055822_bib122","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/en.141.2.850","article-title":"Amylin: A novel action in the brain to reduce body weight","volume":"141","author":"Rushing","year":"2000","journal-title":"Endocrinology"},{"key":"10.1159\/000055822_bib123","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"10.1159\/000055822_bib124","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: Insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1159\/000055822_bib125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF00401833","article-title":"Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin","volume":"38","author":"Young","year":"1995","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-0495(96)90192-4","article-title":"Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36)NH2, amylin, cholecystokinin, and other posssible regulators of nutrient uptake","volume":"45","author":"Young","year":"1996","journal-title":"Metab Clin Exp"},{"key":"10.1159\/000055822_bib127","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/BF01925572","article-title":"Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat","volume":"52","author":"Clementi","year":"1996","journal-title":"Experientia"},{"key":"10.1159\/000055822_bib128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s001250050646","article-title":"Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM","volume":"40","author":"Kong","year":"1997","journal-title":"Diabetologia"},{"key":"10.1159\/000055822_bib129","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s001250051079","article-title":"Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice","volume":"41","author":"Ahren","year":"1998","journal-title":"Diabetologia"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S142439030180051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S142439030180051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T15:36:50Z","timestamp":1682350610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S142439030180051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["S142439030180051X"],"URL":"https:\/\/doi.org\/10.1159\/000055822","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}